Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-006556
Filing Date
2020-09-22
Accepted
2020-09-22 07:14:26
Documents
3
Period of Report
2020-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_092220.htm 6-K 110796
2 GRAPHIC exh991_01.jpg GRAPHIC 65078
3 GRAPHIC exh991_02.jpg GRAPHIC 51991
  Complete submission text file 0001171843-20-006556.txt   273247
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 201187858
SIC: 2834 Pharmaceutical Preparations